USE OF FOLIC ACID AND FOLIC ACID-MODIFIED B CELL LYMPHOMA INDUCING B CELL IMMUNE TOLERANCE AND TARGETING MIGM POSITIVE EXPRESSION

Generally, the present invention relates to the use of folic acid and folate modification in inducing B-cell immune tolerance and targeting mIgM-positively-expressed B-cell lymphoma. The present invention also relates to a method, a pharmaceutical composition and a combination for inducing B-cell im...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHAN, Changyou, JIANG, Zhuxuan, WANG, Huan
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Generally, the present invention relates to the use of folic acid and folate modification in inducing B-cell immune tolerance and targeting mIgM-positively-expressed B-cell lymphoma. The present invention also relates to a method, a pharmaceutical composition and a combination for inducing B-cell immune tolerance and for targeting mIgM-positively-expressed B-cell lymphoma.